▲ +17.27% Upside Potential
This price target is based on 22 analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is $298.78, with a high forecast of $355.00 and a low forecast of $208.00. The average price target represents a 17.27% upside from the last price of $254.79.
The current consensus among 22 contributing investment analysts is to buy stock in Veeva Systems. This Buy consensus rating has held steady for over two years.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, commercial data warehouse, allocation and alignment applications, master data management application, and data and services; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. Veeva Systems has collaboration with RedHill Biopharma Ltd. to enhance value of Opaganib Phase 2/3 COVID-19 clinical data. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California.